Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Endometrial Neoplasms × giredestrant × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Ovarian Neoplasms 1 Neoplasm, Residual 1 Endometrial Neoplasms 1

Interventions

Paclitaxel 31 Carboplatin 23 pembrolizumab 17 Bevacizumab 14 Letrozole 13 Cisplatin 9 Megestrol Acetate 8 dostarlimab 7 olaparib 6 lenvatinib 6 abemaciclib 6 Metformin 6 Radiotherapy 5 Gemcitabine 5 Everolimus 5 rucaparib 4 niraparib 4 durvalumab 4 Specimen Handling 4 Nivolumab 4 Medroxyprogesterone Acetate 4 Fulvestrant 4 Fluorouracil 4 Doxorubicin 4 Docetaxel 4 temsirolimus 3 ridaforolimus 3 mirvetuximab soravtansine 3 avelumab 3 Taxes 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05634499 2026-01-13

EndomERA

Hoffmann-La Roche

Phase 2 Active not recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡